4//SEC Filing
AVEO PHARMACEUTICALS INC 4
Accession 0000899243-17-017790
CIK 0001325879operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:30 PM ET
Size
5.4 KB
Accession
0000899243-17-017790
Insider Transaction Report
Form 4
Dallas Matthew D
VP, Finance
Transactions
- Award
Stock Option (right to buy)
2017-07-03+500,000→ 500,000 totalExercise: $2.22Exp: 2027-07-03→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on June 1, 2018, and the remainder of this option shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Company.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeoperating
Related Parties
1- filerCIK 0001325879
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:30 PM ET
- Size
- 5.4 KB